arrow
G

Guillaume Lessène

University of Melbourne
H指数:47
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins

对渗透的血癌细胞进行再评估试验,测试维奈克拉或选择性靶向促生存BCL2蛋白的其他BH3模拟剂

2025-04-090
OA
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells (Feb,10.1038/s41418-023-01122-3, 2023)
2023-02-240
OAAI
Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms
2022-04-1916
OAAI
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors

洞察药物再利用,以及基于哌啶的SARS-CoV-2 PLpro抑制剂的特异性和复合特性

2022-04-1222
OAAI
BCL-XL antagonism selectively reduces neutrophil life span within inflamed tissues without causing neutropenia
2021-06-0812
OA
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors
2021-03-122
OAAI
Synthesis and Biological Evaluation of (-) and (+)-Spiroleucettadine and Analogues
2021-01-260
PREAI